Back to Top Skip to main content Skip to sub-navigation

Forging of civil-military anvil against COVID-19 focus at GHSA

Image of U.S. and Thai soldiers stand together during a medical exercise. . U.S. Sailors worked side by side with Royal Thai Armed Forces medical professionals during Exercise Cobra Gold 2019 held in February 2019 in Ban Chen Krem, Kingdom of Thailand. The U.S. Sailors, with 3rd Medical Battalion, 3rd Marine Logistics Group, practiced responding to different medical scenarios and utilizing a Role II medical facility with the Royal Thai Armed Forces. (Photo by Navy Lt. Matthew Kelly.)

Recommended Content:

Coronavirus | Global Health Engagement | Health Readiness & Combat Support | Coronavirus and the COVID-19 Vaccine

In a world increasingly forced to go virtual in the face of the COVID-19 pandemic, a ray of hope for far-reaching change came Wednesday in the third annual defense side event on support for the objectives of the civilian-led 2020 Global Health Security Agenda (GHSA).

“Defense partnerships around the world are key,” noted Dr. David Smith, U.S. deputy assistant secretary of defense for health readiness policy and oversight and the panel moderator. He was referring to cutting edge military collaboration ranging from combating weapons of mass destruction worldwide to the fight against COVID-19 amidst brush fires in Australia and malaria outbreaks in remote border regions in South East Asia.

At an event co-hosted by the United States Indo-Pacific Command (USINDOPACOM) and the Australian Defence Force (ADF), the good news emanating from international efforts to increase effective defense sector engagement comes as Thailand hosted the 2020 GHSA Ministerial Meeting. Similar side events have been held online during the months of October and November, with the ministerial meeting’s plenary sessions scheduled for the middle of November.

In achieving the vision of GHSA, Smith added, “the importance of defense sector engagement, including both military-to-military and military-to-civilian collaboration helps ensure a world safe and secure from global health threats posed by infectious diseases, whether naturally occurring, deliberate or accidental.” Given that the challenges posed by COVID vary in size, amount, degree and nature around the world, Smith stressed the importance of international multi-sector cooperation in the finding of answers. “No one has the magic elixir on this one,” he cautioned.

Participation in the event by Major General Tanainit Chotanaphuti, director general of the Royal Thai Army’s Armed Forces Research Institute of Medical Sciences underscored important work, particularly in the fight against infectious diseases, that is supported through hands-on cooperation with international partners. Col. Erik Lombardini, director of U.S. Army Medical Directorate - Armed Forces Research Institute of Medical Sciences, noted that six decades of mutual U.S.-Thai cooperation has been central “in saving hundreds of millions of lives around the globe.”

“We are very excited to have this platform today to highlight some of the key defense partnerships within the Indo-Pacific region that support the objectives of GHSA 2024,” Smith said, “including one which is based right here in Thailand, and which collectively illustrate the importance of defense sector engagement.”

Commodore Nicole Curtis, ADF director general for operational health, offered a unique look at the impact of engagement now carried out at the highest level of government in 54 countries. Such cooperation, she said, is being bolstered both by the use of relevant languages and the unfolding use of webinars that are proving to be both efficient and capable of reaching target populations while COVID restrictions remain in force.

David Lasseter, U.S. deputy assistant secretary of defense for countering weapons of mass destruction, offered a sobering review of the specific importance of international cooperation in the context of the key role played by the Department of Defense in global health security.  The challenges posed by COVID, he noted, include possible impacts on military readiness, the diversion of resources from traditional military missions, and increases in destabilization around the globe.

In the international fight of weapons of mass destruction, Lasseter added, the help of international biosecurity partners is fundamental in improving the safety standards of foreign bio-laboratories. Such cooperation is needed, he noted, in the face of rapidly evolving threats, particularly with an “even more challenging” proliferation of dual use technology. Biological threat reduction efforts, Lasseter said, have involved more than 100 institutions in more than 30 countries since 2004.

Reflecting the need to develop and integrate a defense-oriented platform at the GHSA Ministerial Meetings to encourage defense and security participation and engagement, U.S. Navy Rear Admiral Pamela Miller, a USINDOPACOM surgeon, offered insight into the U.S. model.

“We serve in a complementary and supportive role with our civilian colleagues,” Miller said, pointing to the fact that unique assets held by DOD are given for use by civilian authorities. At the same time, roles carried out by military teams are often “fairly complex and require labor-intensive coordination.”

Echoing Smith’s admonition about supposed COVID-19 elixirs, Miller noted that part of the fight was “trying to learn from the pandemic response.”

You also may be interested in...

DHA- IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

6200.05

Policy

Force Health Protection Quality Assurance (FHPQA) Program

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3
Refine your search
Last Updated: February 09, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.